InvestSMART

Healius Limited (ASX: HLS) - Announcements

Current share price for HLS : $0.440 0.01 (2.33%)+

ASX company news and announcements for Healius Limited (HLS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Healius Limited (HLS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Healius Limited (HLS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Healius Limited (HLS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$320 Ceasing to be a substantial holder 9 Nov 2023 6:17PM $1.850 $0.440 fallen by 76.22%
$320 ACL: Fourth Supplementary Bidder's Statement 9 Nov 2023 6:00PM $1.850 $0.440 fallen by 76.22%
$320 Ceasing to be a substantial holder 7 Nov 2023 5:33PM $1.950 $0.440 fallen by 77.44%
$320 Becoming a substantial holder 3 Nov 2023 7:49PM $1.895 $0.440 fallen by 76.78%
$320 Ceasing to be a substantial holder 2 Nov 2023 8:19PM $1.850 $0.440 fallen by 76.22%
$320 ACL: Extension of offer period - notice of variation 1 Nov 2023 9:38AM $1.810 $0.440 fallen by 75.69%
$320 ACL: Takeover offer for Healius - extension of offer period 1 Nov 2023 9:01AM $1.810 $0.440 fallen by 75.69%
$320 HLS 2023 AGM Letter to Shareholders 27 Oct 2023 8:23AM $1.930 $0.440 fallen by 77.20%
$320 Notice of Annual General Meeting/Proxy Form 27 Oct 2023 8:22AM $1.930 $0.440 fallen by 77.20%
$320 Becoming a substantial holder 23 Oct 2023 8:28PM $2.230 $0.440 fallen by 80.27%
$320 Ceasing to be a substantial holder 19 Oct 2023 7:11PM $2.210 $0.440 fallen by 80.09%
$320 ACL: Notice of fulfilment of conditions 9 Oct 2023 9:38AM $2.220 $0.440 fallen by 80.18%
$320 ACL: Third Supplementary Bidder's Statement 9 Oct 2023 9:34AM $2.220 $0.440 fallen by 80.18%
$320 Application for quotation of securities - HLS 4 Oct 2023 10:28AM $2.210 $0.440 fallen by 80.09%
$320 2023 Annual General Meeting Information 3 Oct 2023 3:37PM $2.210 $0.440 fallen by 80.09%
$320 Ceasing to be a substantial holder from CBA 27 Sep 2023 2:21PM $2.420 $0.440 fallen by 81.82%
$320 Appendix 4G 26 Sep 2023 9:33AM $2.390 $0.440 fallen by 81.59%
$320 Corp Governance 26 Sep 2023 9:32AM $2.390 $0.440 fallen by 81.59%
$320 Annual Report to shareholders 26 Sep 2023 9:29AM $2.390 $0.440 fallen by 81.59%
$320 Change in substantial holding from PPT 25 Sep 2023 4:53PM $2.390 $0.440 fallen by 81.59%
$320 ACL:Takeover offer for Healius-update - ACCC review timeline 22 Sep 2023 9:21AM $2.370 $0.440 fallen by 81.43%
$320 Notification of cessation of securities - HLS 20 Sep 2023 5:28PM $2.360 $0.440 fallen by 81.36%
$320 Change of Director's Interest Notice 14 Sep 2023 2:07PM $2.445 $0.440 fallen by 82%
$320 ACL: Update on offer for Healius and postponement of EGM 14 Sep 2023 8:16AM $2.390 $0.440 fallen by 81.59%
$320 Change of Director's Interest Notice 6 Sep 2023 4:53PM $2.690 $0.440 fallen by 83.64%

301 - 325 of 1041 results

Page 13 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.